Actovegin vs KPV

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Actovegin is primarily a pain management peptide, while KPV is used for immune support.

This page compares Actovegin and KPV across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

ActoveginKPV
CategoryPain ManagementImmune Support
Regulatory status (US)Research use onlyCompounding (Rx) — Apr 2026
Typical dosage5-10 ml500-1000 mcg
Frequencymultiple weeklydaily
Reported benefitsCirculation-related pain relief, tissue oxygenation, healing supportReduces inflammation, immune modulation, gut health support
Reported side effectsRare allergic reactionsVery well-tolerated

Key differences

Primary use. Actovegin is categorised under Pain Management, while KPV falls under Immune Support. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Actovegin: not FDA-approved; treated as a research compound. KPV: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. Actovegin is typically dosed at 5-10 ml (multiple weekly). KPV is typically dosed at 500-1000 mcg (daily).

Can you stack them?

Some protocols combine peptides, but stacking Actovegin and KPV has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Actovegin and KPV?
Actovegin is primarily a pain management peptide, while KPV is used for immune support. Actovegin is not FDA-approved; generally classified as a research compound, whereas KPV is not FDA-approved; compounding permitted with a prescription (as of April 2026).
What is Actovegin used for?
Hypoxic pain and healing.
What is KPV used for?
Anti-inflammatory immune peptide.
Can you take Actovegin and KPV together?
Some users combine peptides within a single protocol, but stacking Actovegin and KPV has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Actovegin or KPV FDA-approved?
Actovegin is not FDA-approved; generally classified as a research compound. KPV is not FDA-approved; compounding permitted with a prescription (as of April 2026).

Read the full articles

  • Actovegin — full monograph: mechanism, research, dosing & references
  • KPV — full monograph: mechanism, research, dosing & references

More Pain Management comparisons

← All peptide comparisons